Cargando…
Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect
Low dose non-toxic disulfide cross-linked micelle (DCM) encapsulated paclitaxel (PTX) was found to be highly efficacious as a radiosensitizer against oral cancer preclinical model. Intensity-modulated radiation therapy was locally administered for three consecutive days 24 h after intravascular inje...
Autores principales: | Jing, Di, Jiang, Nian, Wang, Fengyi, Mao, Chunping, Han, Shujun, Ho, Pui Yan, Xiao, Wenwu, Li, Yuanpei, Li, Jian Jian, Zhang, Lu, Lam, Kit S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021813/ https://www.ncbi.nlm.nih.gov/pubmed/36084485 http://dx.doi.org/10.1016/j.biomaterials.2022.121769 |
Ejemplares similares
-
The Rational Design and Biological Mechanisms of Nanoradiosensitizers
por: Sun, Hainan, et al.
Publicado: (2020) -
A mitochondria-targeted nanoradiosensitizer activating reactive oxygen species burst for enhanced radiation therapy
por: Li, Na, et al.
Publicado: (2018) -
Integrin Targeted Delivery of Radiotherapeutics
por: Liu, Zhaofei, et al.
Publicado: (2011) -
Regulatory T Cells in Radiotherapeutic Responses
por: Schaue, Dörthe, et al.
Publicado: (2012) -
STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
por: Yang, Ping-Lian, et al.
Publicado: (2020)